Cargando…
Corrigendum to “Dual Effects of Cellular Immunotherapy in Inhibition of Virus Replication and Prolongation of Survival in HCV-Positive Hepatocellular Carcinoma Patients”
| Autores principales: | , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Hindawi
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9308510/ https://www.ncbi.nlm.nih.gov/pubmed/35879951 http://dx.doi.org/10.1155/2022/9761463 |
| _version_ | 1784752996221976576 |
|---|---|
| author | Qian, Lei Wang, Nanya Tian, Huimin Jin, Haofan Zhao, Hengjun Niu, Chao He, Hua Ge, Tingwen Han, Wei Hu, Jifan Li, Dan Han, Fujun Xu, Jianting Ding, Xiao Chen, Jingtao Li, Wei Cui, Jiuwei |
| author_facet | Qian, Lei Wang, Nanya Tian, Huimin Jin, Haofan Zhao, Hengjun Niu, Chao He, Hua Ge, Tingwen Han, Wei Hu, Jifan Li, Dan Han, Fujun Xu, Jianting Ding, Xiao Chen, Jingtao Li, Wei Cui, Jiuwei |
| author_sort | Qian, Lei |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9308510 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Hindawi |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-93085102022-07-24 Corrigendum to “Dual Effects of Cellular Immunotherapy in Inhibition of Virus Replication and Prolongation of Survival in HCV-Positive Hepatocellular Carcinoma Patients” Qian, Lei Wang, Nanya Tian, Huimin Jin, Haofan Zhao, Hengjun Niu, Chao He, Hua Ge, Tingwen Han, Wei Hu, Jifan Li, Dan Han, Fujun Xu, Jianting Ding, Xiao Chen, Jingtao Li, Wei Cui, Jiuwei J Immunol Res Corrigendum Hindawi 2022-07-16 /pmc/articles/PMC9308510/ /pubmed/35879951 http://dx.doi.org/10.1155/2022/9761463 Text en Copyright © 2022 Lei Qian et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Corrigendum Qian, Lei Wang, Nanya Tian, Huimin Jin, Haofan Zhao, Hengjun Niu, Chao He, Hua Ge, Tingwen Han, Wei Hu, Jifan Li, Dan Han, Fujun Xu, Jianting Ding, Xiao Chen, Jingtao Li, Wei Cui, Jiuwei Corrigendum to “Dual Effects of Cellular Immunotherapy in Inhibition of Virus Replication and Prolongation of Survival in HCV-Positive Hepatocellular Carcinoma Patients” |
| title | Corrigendum to “Dual Effects of Cellular Immunotherapy in Inhibition of Virus Replication and Prolongation of Survival in HCV-Positive Hepatocellular Carcinoma Patients” |
| title_full | Corrigendum to “Dual Effects of Cellular Immunotherapy in Inhibition of Virus Replication and Prolongation of Survival in HCV-Positive Hepatocellular Carcinoma Patients” |
| title_fullStr | Corrigendum to “Dual Effects of Cellular Immunotherapy in Inhibition of Virus Replication and Prolongation of Survival in HCV-Positive Hepatocellular Carcinoma Patients” |
| title_full_unstemmed | Corrigendum to “Dual Effects of Cellular Immunotherapy in Inhibition of Virus Replication and Prolongation of Survival in HCV-Positive Hepatocellular Carcinoma Patients” |
| title_short | Corrigendum to “Dual Effects of Cellular Immunotherapy in Inhibition of Virus Replication and Prolongation of Survival in HCV-Positive Hepatocellular Carcinoma Patients” |
| title_sort | corrigendum to “dual effects of cellular immunotherapy in inhibition of virus replication and prolongation of survival in hcv-positive hepatocellular carcinoma patients” |
| topic | Corrigendum |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9308510/ https://www.ncbi.nlm.nih.gov/pubmed/35879951 http://dx.doi.org/10.1155/2022/9761463 |
| work_keys_str_mv | AT qianlei corrigendumtodualeffectsofcellularimmunotherapyininhibitionofvirusreplicationandprolongationofsurvivalinhcvpositivehepatocellularcarcinomapatients AT wangnanya corrigendumtodualeffectsofcellularimmunotherapyininhibitionofvirusreplicationandprolongationofsurvivalinhcvpositivehepatocellularcarcinomapatients AT tianhuimin corrigendumtodualeffectsofcellularimmunotherapyininhibitionofvirusreplicationandprolongationofsurvivalinhcvpositivehepatocellularcarcinomapatients AT jinhaofan corrigendumtodualeffectsofcellularimmunotherapyininhibitionofvirusreplicationandprolongationofsurvivalinhcvpositivehepatocellularcarcinomapatients AT zhaohengjun corrigendumtodualeffectsofcellularimmunotherapyininhibitionofvirusreplicationandprolongationofsurvivalinhcvpositivehepatocellularcarcinomapatients AT niuchao corrigendumtodualeffectsofcellularimmunotherapyininhibitionofvirusreplicationandprolongationofsurvivalinhcvpositivehepatocellularcarcinomapatients AT hehua corrigendumtodualeffectsofcellularimmunotherapyininhibitionofvirusreplicationandprolongationofsurvivalinhcvpositivehepatocellularcarcinomapatients AT getingwen corrigendumtodualeffectsofcellularimmunotherapyininhibitionofvirusreplicationandprolongationofsurvivalinhcvpositivehepatocellularcarcinomapatients AT hanwei corrigendumtodualeffectsofcellularimmunotherapyininhibitionofvirusreplicationandprolongationofsurvivalinhcvpositivehepatocellularcarcinomapatients AT hujifan corrigendumtodualeffectsofcellularimmunotherapyininhibitionofvirusreplicationandprolongationofsurvivalinhcvpositivehepatocellularcarcinomapatients AT lidan corrigendumtodualeffectsofcellularimmunotherapyininhibitionofvirusreplicationandprolongationofsurvivalinhcvpositivehepatocellularcarcinomapatients AT hanfujun corrigendumtodualeffectsofcellularimmunotherapyininhibitionofvirusreplicationandprolongationofsurvivalinhcvpositivehepatocellularcarcinomapatients AT xujianting corrigendumtodualeffectsofcellularimmunotherapyininhibitionofvirusreplicationandprolongationofsurvivalinhcvpositivehepatocellularcarcinomapatients AT dingxiao corrigendumtodualeffectsofcellularimmunotherapyininhibitionofvirusreplicationandprolongationofsurvivalinhcvpositivehepatocellularcarcinomapatients AT chenjingtao corrigendumtodualeffectsofcellularimmunotherapyininhibitionofvirusreplicationandprolongationofsurvivalinhcvpositivehepatocellularcarcinomapatients AT liwei corrigendumtodualeffectsofcellularimmunotherapyininhibitionofvirusreplicationandprolongationofsurvivalinhcvpositivehepatocellularcarcinomapatients AT cuijiuwei corrigendumtodualeffectsofcellularimmunotherapyininhibitionofvirusreplicationandprolongationofsurvivalinhcvpositivehepatocellularcarcinomapatients |